Septerna

San Francisco, United States

Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.

Jul 2023

Series B

Top Investors

RA Capital ManagementCatalio Capital ManagementSamsara BioCapitalThird Rock VenturesSoleus Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Septerna's investors?

Septerna's investors include RA Capital Management, Catalio Capital Management, Samsara BioCapital, Third Rock Ventures, Soleus Capital.

Where is Septerna headquartered?

Septerna is headquartered in San Francisco, United States.

What does Septerna do?

Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.

What stage is Septerna at?

Septerna is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 11, 2023.

MLA

"Septerna — Funding & Investors." VCBacked, July 11, 2023, https://www.vcbacked.co/company/septerna. Accessed July 1, 2026.

APA

VCBacked. (2023). Septerna — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/septerna

Wikipedia (cite web)

{{cite web |title=Septerna — Funding & Investors |url=https://www.vcbacked.co/company/septerna |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 11, 2023.